Home  /  Resource Library  /  Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant

Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant

ASH 2020: Results of a study examining brentuximab vedotin for first line treatment of nodular sclerosis syncytial variant Hodgkin lymphoma.